Cargando…

Changes in ocular surface and Meibomian gland after penetrating Keratoplasty

BACKGROUND: To acquire desirable outcomes of penetrating keratoplasty (PKP), various factors affecting graft survival, visual function, and subjective symptom should be considered. As ocular surface and meibomian gland function are associated with these factors, this study aims to investigate change...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kang Yoon, Chung, Byunghoon, Kim, Eung Kweon, Seo, Kyoung Yul, Jun, Ikhyun, Kim, Tae-im
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885585/
https://www.ncbi.nlm.nih.gov/pubmed/33588800
http://dx.doi.org/10.1186/s12886-021-01851-4
_version_ 1783651635653771264
author Kim, Kang Yoon
Chung, Byunghoon
Kim, Eung Kweon
Seo, Kyoung Yul
Jun, Ikhyun
Kim, Tae-im
author_facet Kim, Kang Yoon
Chung, Byunghoon
Kim, Eung Kweon
Seo, Kyoung Yul
Jun, Ikhyun
Kim, Tae-im
author_sort Kim, Kang Yoon
collection PubMed
description BACKGROUND: To acquire desirable outcomes of penetrating keratoplasty (PKP), various factors affecting graft survival, visual function, and subjective symptom should be considered. As ocular surface and meibomian gland function are associated with these factors, this study aims to investigate changes of ocular surface and meibomian gland parameters after PKP. METHODS: This retrospective case series study included 24 eyes of 24 patients who underwent penetrating keratoplasty. Examinations on lipid layer thickness (LLT), meiboscore, tear meniscus area (TMA), tear breakup time (TBUT), corneal fluorescein staining (CFS), Schirmer I test (SIT), Ocular Surface Disease Index (OSDI), and meibomian gland functions were performed before and at 1 week, 1 month, 6 months, and 12 months after surgery. RESULTS: Compared to baseline (2.9 ± 0.6 s), TBUTs were longer at 1 week (4.4 ± 0.5 s, P = 0.027) and 6 months (4.4 ± 0.5, P = 0.048) after surgery. CFS values improved from baseline (6.5 ± 1.1) to 6 months (3.5 ± 0.6, P = 0.023) and 12 months (3.3 ± 0.7, P = 0.001) after surgery. Meibum quality value worsened at 1 week and 12 months after surgery and meibomian gland expressibility value worsened at 1 week and 6 months after surgery compared to baseline. OSDI scores improved at 6 and 12 months after surgery. Meiboscore showed no change throughout the follow up period. The patients with high preoperative meiboscore had worse meibomian gland expressibility at 6 and 12 months and meibum quality at 6 months postoperatively compared to their baseline and to those of patients with low preoperative meiboscore. CONCLUSIONS: After penetrating keratoplasty, ocular surface parameters including corneal staining, TBUT, and OSDI significantly improved whereas meibomian gland parameters showed deteriorations, which was marked in patients with high preoperative meiboscore. Thus, perioperative management of MGD is recommended for patients who undergo penetrating keratoplasty, especially in patients with advanced MGD.
format Online
Article
Text
id pubmed-7885585
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78855852021-02-22 Changes in ocular surface and Meibomian gland after penetrating Keratoplasty Kim, Kang Yoon Chung, Byunghoon Kim, Eung Kweon Seo, Kyoung Yul Jun, Ikhyun Kim, Tae-im BMC Ophthalmol Research Article BACKGROUND: To acquire desirable outcomes of penetrating keratoplasty (PKP), various factors affecting graft survival, visual function, and subjective symptom should be considered. As ocular surface and meibomian gland function are associated with these factors, this study aims to investigate changes of ocular surface and meibomian gland parameters after PKP. METHODS: This retrospective case series study included 24 eyes of 24 patients who underwent penetrating keratoplasty. Examinations on lipid layer thickness (LLT), meiboscore, tear meniscus area (TMA), tear breakup time (TBUT), corneal fluorescein staining (CFS), Schirmer I test (SIT), Ocular Surface Disease Index (OSDI), and meibomian gland functions were performed before and at 1 week, 1 month, 6 months, and 12 months after surgery. RESULTS: Compared to baseline (2.9 ± 0.6 s), TBUTs were longer at 1 week (4.4 ± 0.5 s, P = 0.027) and 6 months (4.4 ± 0.5, P = 0.048) after surgery. CFS values improved from baseline (6.5 ± 1.1) to 6 months (3.5 ± 0.6, P = 0.023) and 12 months (3.3 ± 0.7, P = 0.001) after surgery. Meibum quality value worsened at 1 week and 12 months after surgery and meibomian gland expressibility value worsened at 1 week and 6 months after surgery compared to baseline. OSDI scores improved at 6 and 12 months after surgery. Meiboscore showed no change throughout the follow up period. The patients with high preoperative meiboscore had worse meibomian gland expressibility at 6 and 12 months and meibum quality at 6 months postoperatively compared to their baseline and to those of patients with low preoperative meiboscore. CONCLUSIONS: After penetrating keratoplasty, ocular surface parameters including corneal staining, TBUT, and OSDI significantly improved whereas meibomian gland parameters showed deteriorations, which was marked in patients with high preoperative meiboscore. Thus, perioperative management of MGD is recommended for patients who undergo penetrating keratoplasty, especially in patients with advanced MGD. BioMed Central 2021-02-15 /pmc/articles/PMC7885585/ /pubmed/33588800 http://dx.doi.org/10.1186/s12886-021-01851-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kim, Kang Yoon
Chung, Byunghoon
Kim, Eung Kweon
Seo, Kyoung Yul
Jun, Ikhyun
Kim, Tae-im
Changes in ocular surface and Meibomian gland after penetrating Keratoplasty
title Changes in ocular surface and Meibomian gland after penetrating Keratoplasty
title_full Changes in ocular surface and Meibomian gland after penetrating Keratoplasty
title_fullStr Changes in ocular surface and Meibomian gland after penetrating Keratoplasty
title_full_unstemmed Changes in ocular surface and Meibomian gland after penetrating Keratoplasty
title_short Changes in ocular surface and Meibomian gland after penetrating Keratoplasty
title_sort changes in ocular surface and meibomian gland after penetrating keratoplasty
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885585/
https://www.ncbi.nlm.nih.gov/pubmed/33588800
http://dx.doi.org/10.1186/s12886-021-01851-4
work_keys_str_mv AT kimkangyoon changesinocularsurfaceandmeibomianglandafterpenetratingkeratoplasty
AT chungbyunghoon changesinocularsurfaceandmeibomianglandafterpenetratingkeratoplasty
AT kimeungkweon changesinocularsurfaceandmeibomianglandafterpenetratingkeratoplasty
AT seokyoungyul changesinocularsurfaceandmeibomianglandafterpenetratingkeratoplasty
AT junikhyun changesinocularsurfaceandmeibomianglandafterpenetratingkeratoplasty
AT kimtaeim changesinocularsurfaceandmeibomianglandafterpenetratingkeratoplasty